Literature DB >> 10517950

Presence of up-stream and downstream components of a mitogen-activated protein kinase pathway in the PSD of the rat forebrain.

T Suzuki1, S Mitake, S Murata.   

Abstract

We previously reported the presence of Erk2 type mitogen-activated protein kinase (MAPK) and enrichment of its substrates in the post-synaptic density (PSD) fraction, and suggested a role for MAPK in the synaptic transmission and its modulation [Suzuki, T., Okumura-Noji, K., Nishida, E., ERK2-type mitogen-activated protein kinase (MAPK) and its substrates in post-synaptic density fractions from the rat brain, Neurosci. Res., 22 (1995) 277-285.]. In this paper, synaptic localization of the upstream and downstream components of a MAPK cascade was examined. We found that RSK1, Sos1, N-Shc 66 kDa, N-Shc 52 kDa, and Grb2 were present in the PSD fraction, and cPLA(2) was present in the synaptic plasma membrane fraction. RSK2, Sos2, and N-Shc 46 kDa were not present in the PSD fraction. Post-synaptic localization of RSK1 and Sos1 was confirmed by immunohistochemical examination at the electron microscopic level: the two immunoreactivities were localized in the PSDs, both in the spines and dendrites. These results suggest that all the MAPK cascade components examined were associated with PSD or the synaptic plasma membrane, suggesting the role(s) of the MAPK cascade for synaptic transmission and its regulation at post-synaptic sites.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10517950     DOI: 10.1016/s0006-8993(99)01762-x

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  11 in total

Review 1.  The ERK Pathway: Molecular Mechanisms and Treatment of Depression.

Authors:  John Q Wang; Limin Mao
Journal:  Mol Neurobiol       Date:  2019-02-09       Impact factor: 5.590

2.  Regulation of Group I Metabotropic Glutamate Receptors by MAPK/ERK in Neurons.

Authors:  Li-Min Mao; John Q Wang
Journal:  J Nat Sci       Date:  2016

3.  Interactions and phosphorylation of postsynaptic density 93 (PSD-93) by extracellular signal-regulated kinase (ERK).

Authors:  Ming-Lei Guo; Bing Xue; Dao-Zhong Jin; Li-Min Mao; John Q Wang
Journal:  Brain Res       Date:  2012-05-19       Impact factor: 3.252

4.  p90 RSK-1 associates with and inhibits neuronal nitric oxide synthase.

Authors:  Tao Song; Katsuyoshi Sugimoto; Hideshi Ihara; Akihiro Mizutani; Naoya Hatano; Kodai Kume; Toshie Kambe; Fuminori Yamaguchi; Masaaki Tokuda; Yasuo Watanabe
Journal:  Biochem J       Date:  2007-01-15       Impact factor: 3.857

Review 5.  Mitochondrial involvement in brain function and dysfunction: relevance to aging, neurodegenerative disorders and longevity.

Authors:  V Calabrese; G Scapagnini; A M Giuffrida Stella; T E Bates; J B Clark
Journal:  Neurochem Res       Date:  2001-06       Impact factor: 3.996

6.  Antagonism of Muscarinic Acetylcholine Receptors Alters Synaptic ERK Phosphorylation in the Rat Forebrain.

Authors:  Li-Min Mao; Henry H Wang; John Q Wang
Journal:  Neurochem Res       Date:  2016-12-28       Impact factor: 3.996

7.  Amphetamine increases phosphorylation of MAPK/ERK at synaptic sites in the rat striatum and medial prefrontal cortex.

Authors:  Li-Min Mao; James M Reusch; Eugene E Fibuch; Zhenguo Liu; John Q Wang
Journal:  Brain Res       Date:  2012-11-29       Impact factor: 3.252

8.  H-Ras modulates N-methyl-D-aspartate receptor function via inhibition of Src tyrosine kinase activity.

Authors:  Claire Thornton; Rami Yaka; Son Dinh; Dorit Ron
Journal:  J Biol Chem       Date:  2003-04-14       Impact factor: 5.157

Review 9.  Synaptically Localized Mitogen-Activated Protein Kinases: Local Substrates and Regulation.

Authors:  Li-Min Mao; John Q Wang
Journal:  Mol Neurobiol       Date:  2015-11-14       Impact factor: 5.590

10.  An SK3 channel/nWASP/Abi-1 complex is involved in early neurogenesis.

Authors:  Stefan Liebau; Julie Steinestel; Leonhard Linta; Alexander Kleger; Alexander Storch; Michael Schoen; Konrad Steinestel; Christian Proepper; Juergen Bockmann; Michael J Schmeisser; Tobias M Boeckers
Journal:  PLoS One       Date:  2011-03-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.